EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer-Reference-Cited by-同舟云学术

EGFR Mutation of Tumor and Serum in Gefitinib-Treated Patients with Chemotherapy-Naive Non–small Cell Lung Cancer

Published:2006-03 Issue:3 Volume:1 Page:260-267
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Kimura Hideharu,Kasahara Kazuo,Shibata Kazuhiko,Sone Takashi,Yoshimoto Akihiro,Kita Toshiyuki,Ichikawa Yukari,Waseda Yuko,Watanabe Kazuyoshi,Shiarasaki Hiroki,Ishiura Yoshihisa,Mizuguchi Masayuki,Nakatsumi Yasuto,Kashii Tatsuhiko,Kobayashi Masashi,Kunitoh Hideo,Tamura Tomohide,Nishio Kazuto,Fujimura Masaki,Nakao Shinji

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

2. The ErbB/HER receptor protein-tyrosine kinases and cancer;Roskoski;Biochem Biophys Res Commun,2004

3. The biology of epidermal growth factor receptor in lung cancer;Scagliotti;Clin Cancer Res,2004

4. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung;Rusch;Cancer Res,1993

5. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression;Rusch;Clin Cancer Res,1997

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations;Translational Lung Cancer Research;2021-07

2. EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience;Journal of Cancer Research and Clinical Oncology;2021-05-18

3. Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer;Medicine;2020-10-02

4. The Diagnostic Accuracy of Liquid Biopsy in EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of 40 Studies;SLAS TECHNOLOGY: Translating Life Sciences Innovation;2020-07-13

5. Pneumonitis in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitor: Meta-analysis of 153 cohorts with 15,713 patients;Lung Cancer;2018-09